Medical Device News Magazine

iBloodPressure Reduces Hypertension in 71 Percent of Patients

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

iBloodPressure monitoring device and data platform for hypertension by Smart Meter, data showed that 71 percent of the patients with elevated levels of hypertension saw a reduction after only 3-½ months of using the iBloodPressure.

The iBloodPressure is a cellular-connected blood pressure monitoring system that automatically transmit blood pressure data to a remote patient monitoring system or electronic health record (EHR) system (including PointClickCare).

This provides more accurate tracking of blood pressure data and saves staff time in healthcare facilities by not having to manually write down or input results.

During the 14 weeks that results were noted, 88 percent of the participants who had the highest levels of blood pressure readings (Stage II) saw a reduction in blood pressure levels and 75 percent of them stepped down one stage or more.

Even the participants who started at a lower level of high blood pressure (Stage I), saw improvements, with 71 percent seeing a reduction in their results and 50 percent stepping down one stage or more.

“Using the cellular-connected iBloodPressure to track trends in a patient’s blood pressure is easy in any setting and provides greater access to the data for both the provider and the patient,” said Casey Pittock, Smart Meter CEO.

He added, “This ease-of-use improves patient engagement so that the patient will utilize the device as prescribed by their provider, which leads to better health outcomes.”

Smart Meter’s iBloodPressure is being utilized in many healthcare settings, including remote patient monitoring programs by physicians, long-term care facilities, and home care providers.

“We have seen great results with iBloodPressure from the many physician practices our Remote Patient Monitoring Platform and services support”, said Samson Magid, CEO of HealthSnap. “The health care professionals we serve appreciate the simplicity and reliability of this cellular blood pressure device from Smart Meter.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”